Navigation Links
Occlutech and IZASA Obtains Favourable Ruling in Proceeding Initiated by AGA Medical in Spain
Date:9/21/2009

ZURICH, September 21 /PRNewswire/ -- Occlutech AG, the leading European developer of products for septal closure, today announced that, together with its partner in Spain IZASA SA, it defeated a request for an injunction against sales and marketing activities in Spain, launched at the Commercial Court I of Barcelona, Spain by its U.S. competitor AGA Medical.

The request by AGA was based on alleged patent infringement and unfair competition claims related to wrongful assumptions and misleading statements about the outcome of a recent ruling by the patent court in Dusseldorf and about Occlutech.

The Court came to the conclusion that Occlutech's products offered for sale by IZASA do not infringe patent EP0808138 held by AGA in Spain that is Europe's fifth largest market.

Further in October 2008 Occlutech won against AGA Medical in the District Court of The Hague. In December 2008 the Higher Regional appeal Court in Dusseldorf, that has no jurisdiction over sales by Occlutech's partners outside of Germany, decided against Occlutech. In July 2009, however, the Patents Court of the High Court of Justice, London declared that Occlutech's products are not infringing AGA's patent EP 0808138.

Above Court decisions are not final and subject to appeal that are/can be filed by AGA or Occlutech.

Occlusion devices are used to treat structural heart disease, including structural heart defects and abnormalities such as Atrial Septal Defects, (ASD), and Patent Foramen Ovale (PFO, an undesired channel between the heart's two atria, present in up to 25% of the population), in minimally invasive, non-surgical procedures. The market for PFO occluders is expected to expand significantly as the link between PFO and stroke, that is the third most common cause of death, as well as severe migraine becomes increasingly well documented.


'/>"/>
SOURCE Occlutech AG
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Occlutech Wins Confirmation of its Intellectual Property Position Versus AGA Medical Patent by AIPPI
2. AGA Medical to Appeal Ruling by Dutch Court in Lawsuit With Occlutech GmbH
3. AGA Medical Corporation Begins Proceedings Against Occlutech to Recover Damages
4. Occlutech Obtains CE Mark for the new Generation PFO & ASD Occluders
5. GlaxoSmithKline Obtains Exclusive U.S. OTC Marketing Rights to MEVACOR(R) (lovastatin) from Merck & Co., Inc.
6. Patient Lift Manufacturer, Medcare Products, Obtains Women-Owned Certification
7. Aspreva obtains shareholder approval for acquisition by Galenica
8. VIE Healthcare Expands Its Operations in the Midwest, and Obtains First Local Client
9. DRAXIS Obtains Interim Order for Proposed Arrangement
10. DRAXIS Obtains Final Order for Proposed Arrangement
11. China Medicine Corporation Obtains Australian Patent for rADTZ
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... ... January 21, 2017 , ... "ProDOF is the perfect set of tools for video editors that ... a scene," said Christina Austin - CEO of Pixel Film Studios. , Video editors ... the illusion of a DSLR racking focus from one area into the next. ProDOF ...
(Date:1/21/2017)... , ... January 21, 2017 , ... Phytocéane ... Ocean, isolated from the rest of the world with ZANZIBAR SHOWER GEL. Inspired by ... used key ingredients, Virgin Coconut Oil and moisturizing vegetal coral to create this gentle, ...
(Date:1/21/2017)... ... January 21, 2017 , ... ... Dermatology has recently joined their multi-specialty medical group. The dermatology practice provides ... services. , “We’re excited to add this excellent dermatology practice to our group’s ...
(Date:1/21/2017)... ... ... In the United States, 20 million women and 10 million men suffer with ... for having struggled with an eating disorder as well as common co-occurring conditions like ... After an Eating Disorder” -- to be featured at this year’s iaedp Symposium -- ...
(Date:1/20/2017)... ... 2017 , ... Spectrum Aquatics Launches New ADA Portable Motion Trek BP 300 Lift. Built for ... mounted on wheels, it can be wheeled out of the way and stored when not ... deck. "We have transformed the feedback from customers into specific enhancements and created a new ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , January 19, 2017 Incretin Mimetics/GLP-1 Agonists, ... Others The global anti-obesity drugs market is ... half of the forecast period and CAGR of 38.7% in the ... grow at a CAGR of 32.8% from 2016 to 2027. The ... 2021, and $24,063 million in 2027. ...
(Date:1/19/2017)... SUNNYVALE, Calif. , Jan. 19, 2017 ... that its CyberKnife® and TomoTherapy® Systems continue to set ... systems received the highest composite overall user satisfaction rating ... to the Q4 2016 MD Buyline Market Intelligence Briefing™. ... achieved the highest composite ratings among industry peers for ...
(Date:1/19/2017)... January 19, 2017 ... Oncology & Haematology, 2016;12(Suppl 2):3-8; http://www.touchoncology.com/articles/optimising-clinical-outcomes-gastrointestinal-cancers-through-inhibiting-angiogenesis-and ... ... Published recently in a supplement to ... from touchONCOLOGY, an article by James Gilbart ...
Breaking Medicine Technology: